The policy covers pharmaceutical products, bulk drugs, active pharmaceutical ingredients, key starting materials, drug intermediates, medical devices and related manufacturing infrastructure
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.